KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Edwards Lifesciences (EW) over the last 11 years, with Q3 2025 value amounting to $2.7 million.

  • Edwards Lifesciences' Other Non Operating Income fell 9032.26% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year decrease of 484.69%. This contributed to the annual value of $68.9 million for FY2024, which is 39568.35% up from last year.
  • As of Q3 2025, Edwards Lifesciences' Other Non Operating Income stood at $2.7 million, which was down 9032.26% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Other Non Operating Income ranged from a high of $33.3 million in Q4 2024 and a low of -$3.3 million during Q1 2022
  • Moreover, its 5-year median value for Other Non Operating Income was $2.7 million (2025), whereas its average is $5.5 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 156666.67% in 2021, then crashed by 24285.71% in 2022.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Other Non Operating Income stood at $1.4 million in 2021, then soared by 314.29% to $5.8 million in 2022, then plummeted by 37.93% to $3.6 million in 2023, then surged by 825.0% to $33.3 million in 2024, then tumbled by 91.89% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, -$1.3 million for Q2 2025, and $2.6 million during Q1 2025.